- Home
- LICN vs BME Comparison
LICN vs BME Comparison
Compare LICN & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LICN
- BME
- Stock Information
- Founded
- LICN 2004
- BME 2005
- Country
- LICN China
- BME United States
- Employees
- LICN N/A
- BME N/A
- Industry
- LICN
- BME Trusts Except Educational Religious and Charitable
- Sector
- LICN
- BME Finance
- Exchange
- LICN Nasdaq
- BME Nasdaq
- Market Cap
- LICN 2.1M
- BME 462.3M
- IPO Year
- LICN 2023
- BME N/A
- Fundamental
- Price
- LICN $3.31
- BME $36.12
- Analyst Decision
- LICN
- BME
- Analyst Count
- LICN 0
- BME 0
- Target Price
- LICN N/A
- BME N/A
- AVG Volume (30 Days)
- LICN 50.3K
- BME 34.0K
- Earning Date
- LICN 01-01-0001
- BME 01-01-0001
- Dividend Yield
- LICN N/A
- BME 6.26%
- EPS Growth
- LICN N/A
- BME N/A
- EPS
- LICN N/A
- BME 1.44
- Revenue
- LICN $41,477,000.00
- BME N/A
- Revenue This Year
- LICN N/A
- BME N/A
- Revenue Next Year
- LICN N/A
- BME N/A
- P/E Ratio
- LICN N/A
- BME $28.37
- Revenue Growth
- LICN 4.32
- BME N/A
- 52 Week Low
- LICN $0.04
- BME $35.53
- 52 Week High
- LICN $7.55
- BME $43.20
- Technical
- Relative Strength Index (RSI)
- LICN 45.62
- BME 41.49
- Support Level
- LICN $3.26
- BME $36.09
- Resistance Level
- LICN $3.96
- BME $37.65
- Average True Range (ATR)
- LICN 0.39
- BME 0.50
- MACD
- LICN -0.03
- BME 0.05
- Stochastic Oscillator
- LICN 3.64
- BME 26.44
About LICN Lichen China Limited
Lichen International Ltd formerly Lichen China Ltd is a holding company. The company, along with its subsidiaries provides financial and taxation solution services; education support services; and software and maintenance services. The company generates Majority revenue from Financial and taxation solution services.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.